Arena Pharmaceuticals Inc (NASDAQ:ARNA) - Share price - Overview

Stock Report

Arena Pharmaceuticals Inc ARNA

Last Price
$46.40

Day Change
0.20|0.43%

As of 23/05/2018
19:07:52 EDT | USD
Minimum 15 Minutes Delay.

Last Close46.20
Day Range45.87 - 46.95
Mkt Cap2.28Bil
52-Wk Range12.20 - 47.64
Yield %-
ISINUS0400476075
Volume455,408
P/E-16.87
P/S80.00
P/CF-21.35

Share Price

Financials
201520162017
More ...
Income Statement
Revenue38.33123.9821.34
Operating Income-99.2310.97-79.99
Net Income-107.98-22.52-91.41
Basic EPS-4.50-0.90-2.77
Avg. Diluted Shares Outstanding242433
Balance Sheet
Current Assets174.84119.89281.28
Non Current Assets81.9549.1258.00
Total Assets256.79169.01339.28
Current Liabilities49.9063.8872.33
Total Liabilities---
Total Equity53.5439.90207.14
Cash Flow
Operating Cash Flow-98.11-62.14-66.64
Capital Expenditure-10.99-0.95-0.11
Free Cash Flow-109.11-63.09-66.76

In millions, except "Basic EPS". Currency is USD.

Company Profile

Arena Pharmaceuticals Inc is a biopharmaceutical company. The Company is engaged in discovering, developing and commercializing novel drugs that target G protein-coupled receptors, or GPCRs, to address unmet medical needs.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

159
Key Stats
More ...
Price/Earning TTM-17.30
Price/Book3.89
Price/Sales TTM71.45
Rev Growth (3 year avg)-16.74
EPS Growth (3 year avg)-
Operating Margin % TTM-374.90
Net Margin % TTM-428.40
ROE TTM-74.00
Debt/Equity0.28
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.